Prevention of early interstitial pneumonitis (IP) after BMT by exclusion of CMV-IG-POS platelet donors, prophylaxis with CMV immune globuline, and by a modified TBI regimen.
Hinterberger
W
W
1st Department of Medicine, Univ Vienna, Austria.
Alth
G
G
Höcker
P
P
Kallinger
W
W
Kier
P
P
Kolbabek
H
H
Lechner
K
K
Popov-Kraup
T
T
D000741:Anemia, Aplastic / Q000601:surgery; D001317:Austria / Q000453:epidemiology; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D007116:Immunization, Passive; D015994:Incidence; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D009369:Neoplasms / Q000601:surgery; D017713:Platelet Transfusion; D011658:Pulmonary Fibrosis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D011879:Radiotherapy Dosage; D014019:Tissue Donors; D014916:Whole-Body Irradiation / Q000379:methods*